Latest / Stock Movers / Weekly Roundup: Meta's AI-Driven Rally, Gen Digital Drops, Moderna Surges
Transcript
- 0:02Speaker 1: Bloomberg Audio Studios.
- 0:04Speaker 2: Podcasts. Radio. News. The Stock Movers Report. Your roundup of
- 0:11Speaker 2: companies making moves in the stock market. Harnessing the power
- 0:14Speaker 2: of Bloomberg data.
- 0:16Speaker 3: I'm Tim Stanevek with Carol Massa. We're joined by Bloomberg
- 0:19Speaker 3: News equities reporter Avalon Purnell.
- 0:21Speaker 1: Hey, Avalon.
- 0:21Speaker 3: Hi.
- 0:22Speaker 1: She keeps coming back even though... She does. We are
- 0:25Speaker 1: impossible to deal with. She puts up with us like
- 0:27Speaker 1: no other. Let's talk about meta. We've been talking about
- 0:30Speaker 1: meta a lot this week.
- 0:31Speaker 4: Ticker meta, it jumped 13% in the week at its
- 0:34Speaker 4: highest level in over a year. And that's after its
- 0:37Speaker 4: AI agent, Muse, became the top downloaded free app on
- 0:40Speaker 4: Apple's App Store. And yeah, the tool is really helping
- 0:44Speaker 4: to push the shares even close to the $ 2 trillion mark.
- 0:47Speaker 1: Are you musing yet? You go to Instagram and it
- 0:50Speaker 1: just pops up, that little creature. That's what they do, though.
- 0:53Speaker 2: I know.
- 0:53Speaker 1: Wait, I thought you didn't have Instagram. Oh, interesting. I
- 0:57Speaker 1: don't know why I have it. I've never been a
- 1:00Speaker 1: Facebook user. Very interesting. But for some reason, I got
- 1:04Speaker 1: into Instagram. So it's there.
- 1:06Speaker 2: Okay.
- 1:07Speaker 3: Well, you're part of the 40% of this entire world
- 1:09Speaker 3: that uses a product made by Mark Zuckerberg's company.
- 1:11Speaker 1: So welcome. We're talking about, though, meta and their AI, though, right?
- 1:15Speaker 2: We're talking about it now in a big way.
- 1:18Speaker 3: And the stock investors certainly moved into it.
- 1:20Speaker 1: It's remarkable.
- 1:20Speaker 3: I mean, the stock is up more than 700% since 2022.
- 1:23Speaker 3: It's up around 40% since just last month.
- 1:28Speaker 1: So I don't know.
- 1:29Speaker 2: Exactly.
- 1:30Speaker 4: It's actually on track potentially to have its best month
- 1:33Speaker 4: since 2013. We'll have to obviously see what happens next week.
- 1:36Speaker 3: It was barely a public company back in 2013.
- 1:39Speaker 1: Kind of amazing, right?
- 1:41Speaker 2: I love watching the runs of some of these different companies.
- 1:43Speaker 1: Go to ticker G-E-N for us.
- 1:45Speaker 4: Yes, GenDigital, which for those unaware, this is the company
- 1:49Speaker 4: that makes the antivirus software Norden 360. And so they
- 1:53Speaker 4: dropped 25% this week to have their worst weekly drop
- 1:56Speaker 4: since 2020. And that's after a media report said that
- 1:58Speaker 4: they are considering potentially in an early talks to take
- 2:01Speaker 4: over GoDaddy.
- 2:02Speaker 1: Yeah.
- 2:03Speaker 3: And GoDaddy was on a tear to the upside, but
- 2:05Speaker 3: not so happy for the acquirer.
- 2:07Speaker 1: Gen Digital. Yeah. The maker of Norton Antivirus. Did you
- 2:10Speaker 1: not hear what she just said?
- 2:11Speaker 3: Yeah.
- 2:11Speaker 1: I know. I know. But that's like- He does listen.
- 2:13Speaker 1: But that's what we all say. Men.
- 2:15Speaker 2: Oh, okay. I'm just kidding.
- 2:18Speaker 1: It wouldn't be a.
- 2:18Speaker 3: Friday if I didn't repeat something that Avalon said.
- 2:21Speaker 1: Not like I never repeat something you just said. All right,
- 2:24Speaker 1: so Gen Digital, again, how.
- 2:25Speaker 3: Much was it down this week?
- 2:27Speaker 4: Down 25%. All right, big hit, big hit.
- 2:29Speaker 1: All right, let's go to your world.
- 2:31Speaker 4: Yes, Moderna, that's ticker mRNA. It's surged 29% to end
- 2:35Speaker 4: the week at its highest level since 2022. It's amazing.
- 2:38Speaker 4: And that's after it confirmed that it is going to
- 2:40Speaker 4: be presenting additional data on its personalized cancer vaccine next month.
- 2:44Speaker 1: This is the one it's doing with Merck?
- 2:46Speaker 2: Yes.
- 2:46Speaker 4: Yes.
- 2:48Speaker 1: This is a big deal. Is this just melanoma right now?
- 2:51Speaker 2: Yes.
- 2:52Speaker 1: But the idea is that it will work for everything?
- 2:55Speaker 4: Not necessarily everything, but that it could actually hit other
- 2:59Speaker 4: areas that maybe could have a higher TAMP.
- 3:04Speaker 2: The Stock Movers Report from Bloomberg Radio. Check back with
- 3:08Speaker 2: us throughout the day for the latest roundup of companies
- 3:10Speaker 2: making news on Wall Street. And for the latest market-moving headlines,
- 3:15Speaker 2: listen to Bloomberg Radio live. Catch us on YouTube, Bloomberg.com,
- 3:19Speaker 2: and on Apple CarPlay and Android Auto with the Bloomberg
- 3:22Speaker 2: Business app.